Risperidone versus placebo for aggression following traumatic brain injury: a feasibility randomised controlled trial. (2020)

First Author: Deb S
Attributed to:  Cognition and Behaviour funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2019-036300

PubMed Identifier: 32912978

Publication URI: http://europepmc.org/abstract/MED/32912978

Type: Journal Article/Review

Volume: 10

Parent Publication: BMJ open

Issue: 9

ISSN: 2044-6055